Dietitians play essential role in effective management of Type 1 and Type 2 diabetes in adults

November 23, 2010

St. Louis, MO, 23 November, 2010 - Proper nutrition therapy is essential for the successful management of type 1 and type 2 diabetes and registered dietitians (RDs) can play a key role as part of the health care team. An article in the December issue of the Journal of the American Dietetic Association reviews the evidence and nutrition practice recommendations presented in the American Dietetic Association Nutrition Practice Guidelines for Type 1 and Type 2 Diabetes in Adults. This complete and systematic review presents 29 key nutrition practice guidelines in order to best support people with diabetes.

According to Marion J Franz, MS, RD, lead author and noted nutrition consultant, "This publication has reviewed the process for developing the guidelines, identified major and contributing factors for diabetes nutrition therapy, reviewed and summarized research, and stated the nutrition practice recommendations that are to be integrated into the nutrition care process. The nutrition practice guidelines provide recommendations for assessing client/patient needs and for selecting interventions, monitoring and evaluating outcomes. The evidence is strong that medical nutrition therapy provided by RDs is an effective and essential therapy in the management of diabetes. RDs are uniquely skilled in this process."

The authors conducted a thorough review of the research literature to distill evidence-based nutrition recommendations and practice guidelines regarding the major nutrition therapy factors - carbohydrates (intake, sucrose, non-nutritive sweeteners, glycemic index, fiber), protein intake, cardiovascular disease, and weight management. Armed with information regarding what works and why, RDs can encourage lifestyle changes and select appropriate interventions based on key recommendations that include consistency in day-to-day carbohydrate intake, adjusting insulin doses to match carbohydrate intake, substitution of sucrose-containing foods, usual protein intake, cardioprotective nutrition interventions, weight management strategies, regular physical activity, and use of self-monitored blood glucose data.

Key recommendations:
-end-
The article is "The Evidence for Medical Nutrition Therapy for Type 1 and Type 2 Diabetes in Adults" by Marion J Franz, MS, RD; Margaret A Powers, PhD, RD; Carolyn Leontos, MS, RD; Lea Ann Holzmeister, RD; Karmeen Kulkarni, MS, RD; Arlene Monk, RD; Naomi Wedel, MS, RD; and Erica Gradwell, MS, RD. It appears in the Journal of the American Dietetic Association, Volume 110 Issue 12 (December 2010) published by Elsevier.

In an accompanying podcast interview lead author Marion J Franz, MS, RD, and Kari Kren, MPH, RD, LD, Manager, Evidence-based Practice, Research & Strategic Business Development, ADA, discuss the importance and implications of "The Evidence for Medical Nutrition Therapy for Type 1 and Type 2 Diabetes in Adults." It is available at http://adajournal.org/content/podcast.

Notes for Editors

Full text of this article is available to journalists upon request. Contact Nancy Burns at 314-447-8013 or adajmedia@elsevier.com to obtain copies.

Journalists wishing to set up interviews with Marion J. Franz may contact her at 952-941-6751 (office), 952-270-0194 (mobile), or MarionFranz@aol.com.

An audio podcast featuring an interview with lead author Marion J. Franz, MS, RD, and Kari Kren, MPH, RD, LD, Manager, Evidence-based Practice, Research & Strategic Business Development, American Dietetic Association (under embargo until November 23, 2010, 12:01 AM ET) ) and information specifically for journalists are located at http://adajournal.org/content/mediapodcast. Excerpts from the podcast may be reproduced by the media; contact Nancy Burns to obtain permission.

About the Authors

Marion J Franz, MS, RD
Nutrition/Health Consultant, Nutrition Concepts by Franz, Inc., Minneapolis, MN

Margaret A Powers, PhD, RD
Research Scientist, International Diabetes Center at Park Nicollet, Minneapolis, MN

Carolyn Leontos, MS, RD
Professor Emeritus, University of Nevada Cooperative Extension, Las Vegas, NV

Lea Ann Holzmeister, RD
Pediatric Nutritionist, Phoenix Children's Hospital, Phoenix, AZ

Karmeen Kulkarni, MS, RD
Director, Scientific Affairs, Abbott Diabetes Care, Salt Lake City, UT

Arlene Monk, RD
Research Clinician, International Diabetes Center at Park Nicollet, Minneapolis, MN

Naomi Wedel, MS, RD
Clinical Specialist, Roche Diagnostics, Madison, WI

Erica Gradwell, MS, RD
Lead Evidence Analyst/ Independent Contractor, American Dietetic Association, Arvada, CO

About the Journal of the American Dietetic Association

The official journal of the American Dietetic Association (www.eatright.org) the Journal of the American Dietetic Association (www.adajournal.org) is the premier source for the practice and science of food, nutrition and dietetics. The monthly, peer-reviewed journal presents original articles prepared by scholars and practitioners and is the most widely read professional publication in the field. The Journal focuses on advancing professional knowledge across the range of research and practice issues such as: nutritional science, medical nutrition therapy, public health nutrition, food science and biotechnology, food service systems, leadership and management and dietetics education.

The Journal has been ranked 16th of 66 journals in Impact Factor in the Nutrition and Dietetics category of the Journal Citation Reports® 2010, published by Thomson Reuters, with an impact factor of 3.128.

About the American Dietetic Association

The American Dietetic Association (www.eatright.org) is the world's largest organization of food and nutrition professionals. ADA is committed to improving the nation's health and advancing the profession of dietetics through research, education and advocacy.

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including the Lancet (www.thelancet.com) and Cell (www.cell.com), and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect (www.sciencedirect.com), Scopus (www.scopus.com), Reaxys (www.reaxys.com), MD Consult (www.mdconsult.com) and Nursing Consult (www.nursingconsult.com), which enhance the productivity of science and health professionals, and the SciVal suite (www.scival.com) and MEDai's Pinpoint Review (www.medai.com), which help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier (www.elsevier.com) employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC (www.reedelsevier.com), a world-leading publisher and information provider. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Elsevier

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.